Advanced Pancreatic Cancer
57
10
14
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.5%
2 terminated out of 57 trials
90.5%
+3.9% vs benchmark
7%
4 trials in Phase 3/4
16%
3 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 19 completed trials
Clinical Trials (57)
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer
IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer
1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma
Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases
A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer
A Clinical Study Evaluating a New Treatment Strategy for Patients With Advanced Pancreatic Cancer Who Have Not Received Prior Treatment for Advanced Disease.
ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Pancreatic Adenocarcinoma Signature Stratification for Treatment
Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.
APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
A Real-world Study of Liposomal Irinotecan (Onivyde)-Based Therapy in Patients With Locally Advanced/Metastatic Pancreatic Cancer in China
A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced Pancreatic Cancer
Statin Addition to Chemotherapy for Advanced Pancreatic Cancer
A Study of Irinotecan Liposome in Advanced Pancreatic Cancer